BNET Industries
Last Fiscal Year Sales:$297.1M
- Public
- CH
Dow Jones Description
Specialty Chemicals Mfr
Number of Employees 6,146
Peer Companies
NAICS Code All Other Miscellaneous Chemical Product and Preparation Manufacturing: 325998
Recent Events
-
ProChon Biotech Selects Lonza to Locally Manufacture Critical Component of BioCartTM...
-
Week of Oct. 19, 2009: Lonza Drops Bid for Patheon; Peregrine Appoints Head of Regulatory...
-
Morphotek Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement
News & Analysis
Filter by
lonza group ltd. - All News and Analysis
Teva and Lonza Announce Strategic Partnership to Become a Leading Global Provider of Biosimilars
- 2009-01-20
JERUSALEM & BASEL, Switzerland -- Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Lonza Group Ltd. (SIX: LONN) today announced their agreement to establish a joint venture to develop, manufacture and market a portfolio of biosimilars. Through this joint venture, Lonza and Teva bring together highly complementary capabilities that will significantly...
Altus Pharmaceuticals Secures ALTU-135 Commercial Manufacturer
- 2006-11-17
Lonza Selected as Altus' ALTU-135 Commercial Manufacturer CAMBRIDGE, Mass. -- Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company focused on oral and injectable protein therapeutics for patients with gastrointestinal and metabolic disorders, announced today that it has signed a long-term agreement with Lonza Group Ltd (SWX: LONN), to commercially...
Sanofi Pasteur PER.C6(R)-based Seasonal Influenza Vaccine Enters First Clinical Trial
- 2006-09-26
* Flu vaccine based on new technology within U.S. Government Preparedness Program * Successful scale-up of PER.C6® to 20,000 liters Lyon, France; Leiden, The Netherlands, September 26, 2006 - Sanofi pasteur, the vaccines business of the sanofi-aventis Group (NYSE: SNY), initiated its first...
Sanofi pasteur Cell Culture-Based Seasonal Influenza Vaccine Enters First Clinical Trial.
- 2006-09-26
SWIFTWATER, Pennsylvania & LYON, France, September 26 /PRNewswire/ -- - Flu Vaccine Based on New Technology Within U.S. Government Preparedness Program Sanofi pasteur, the vaccines business of the sanofi-aventis Group (NYSE: SNY), initiated its first clinical study today with a...
Lonza further invests in China.(Lonza Group)(Brief article)
- 2006-07-06
Lonza Group announced its commitment to substantially further invest in Nansha of Guangzhou, Guangdong province. The expansion activities will enhance Lonza's existing production operations in Guangzhou. The pledged investment is the result of a signed letter of intent between Lonza Group and Nansha authorities. The strategic...
Lonza Group
- 2006-06-19
Joseph Colleluori has been named head of corporate development for Lonza Group. He will be based at the global headquarters in Basel, Switzerland. Previously, Colleluori worked for Merck as vp of marketing and strategic development for Lonza Custom Manufacturing.
CHINA: Construction plans for proposed $200,000,000 fine chemical plants, LONZA GROUP [Switzerland] Order #: 052806.
- 2006-05-01
PROJECT OVERVIEW The Switzerland-based LONZA GROUP has been active in China since 1995 when the company selected Guangzhou City to be its front in the country. According to Steven Borgas, LONZA Chief Executive Officer, his company believes that the Guangzhou region offers cutting-edge...
LONZA GROUP SETTING UP WORLD-CLASS FINE CHEMICAL R&D CENTER
- 2006-04-03
According to fdi.gov.cn: The top-class pharmaceutical and fine chemical R&D center in China, the one funded by Swiss company Lonza was launched for use yesterday. With a total investment of 4.35 million USD in R&D facilities, the center boasts the strongest R&D capability among its industry peers and is staffed...
Preservative alternative.(Lonza Group Ltd. introduces cosmetic preservatives)(Brief Article)
- 2005-12-01
Lonza launched Geogard[R] Ultra to meet the growing demand for alternative cosmetic preservatives. The ingredient functions by creating a more hostile environment within the formulation for microbes to overcome. According to Lonza, it also provides greater utility with its multifunctional action. Geogard[R] Ultra's global regulatory ...
Lonza Group.(On the Move)
- 2005-09-01
GERHARD KLEMENT has accepted the newly created position of chief technology officer at the Lonza Group. Klement will be responsible for research and development of new and current technologies, with a major focus on biotechnology.
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Stefan Borgas | CEO |
| Roland Waibel | CFO |
| Toralf Haag | Chief Financial Officer |
| Alexandre Pasini | Manager, Ir |
| Arthur Merkle | Head of Corporate Training & Development |
| Beat In Albon | Head, Organic Fine Chemicals |
| Claudio Abacherli | |
| Dominik Werner | |
| Gerhard Klement | Head, Biopharmaceuticals Business Sector |
| Gines Garcia | |
| Guido Lularevic | Data Processing Executive |
| Karin Senggen | Apprentice |
| Lukas Utiger | Head, Exclusive Synthesis Business Sector |
| Marcela Cechova | Head of Global Human Resources |
| Nicola Rakovic | Apprentice |
| Rosario Valido | Head, Polymer Intermediates |
| Stephan Rosenberger | Head of Cq |
| Uwe H Bohlke | Head of Exclusive Synthesis |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Sir Richard Sykes | Deputy Chairman |
| Bernard Mach | Vice Chairman |
| Daphne Jackson | Board of Directors |
| Gerhard N. Mayr | Board of Directors |
| Peter Kalantzis | Board of Directors |
| Peter Matter | Board of Directors |
| Rolf Soiron | Board of Directors |
| Rupert Gasser | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | CEO | Current |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | CFO | Current |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | Chief Financial Officer | Current |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | Manager, Ir | Current |
Arthur Merkle is Head of Corporate Training & Development with the Lonza Group in Basel, Switzerland. Arthur has held various senior management positions and consulted in the fields of HR, Training and Healthcare in Southern Africa over the past 15 years. He started his career in the South African Air Force as an Air Traffic Controller and graduated from the Military Academy in 1989. He is passionate about people development and enjoys living in Europe since mid 2005.
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | Head of Corporate Training & Development | Current |
| Online Educa Berlin 2008 | Current |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | Head, Organic Fine Chemicals | Current |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | Current |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | Current |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | Head, Biopharmaceuticals Business Sector | Current |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | Current |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | Data Processing Executive | Current |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | Apprentice | Current |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | Head, Exclusive Synthesis Business Sector | Current |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | Head of Global Human Resources | Current |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | Apprentice | Current |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | Head, Polymer Intermediates | Current |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | Head of Cq | Current |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | Head of Exclusive Synthesis | Current |
| Organization | Position | Status |
|---|---|---|
| The Research and Development Society | President | Current |
| King's College London | Fellow | Current |
| Lonza Group Ltd. | Deputy Chairman | Current |
| Ukscf | Chairman | Current |
| Circassia Ltd | Non-Executive Chairman | Current |
| BioCeramic Therapeutics Ltd. | Chairman | Current |
| Combinature Biopharm AG | Chairman | Current |
| Rio Tinto plc | Chairman | Current |
| The Natural History Museum | Board of Directors | Current |
| APP Pharmaceuticals, Inc. | Board Director | Current |
| Eurasian Natural Resources Corporation | Board of Directors | Current |
| Rio Tinto Limited | Board of Directors | Current |
| King's College | Fellow | Current |
| King's College London | Fellow | Current |
| The Royal Society | Fellow | Current |
| BioCeramic Therapeutics Ltd. | Rector | Former |
| Lincoln College | Fellow | Former |
| GlaxoSmithKline Plc | Chairman | Former |
| University of London | Doctor of Science Degree | Former |
| University of Madrid | Doctorate In Pharmacy | Former |
| University of Birmingham | Doctorate | Former |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | Vice Chairman | Current |
| Lonza Group Ltd. | Vice Chairman | Current |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | Board of Directors | Current |
Gerhard N. Mayr, Independent Director, Member of the Remuneration and Appointments Committee. A native of Austria, Gerhard Mayr received a master's degree in chemical engineering from the Swiss Federal Institute of Technology (Zurich, Switzerland) in 1969, and a master of business administration degree from Stanford University in 1972. In March, 2004, Gerhard Mayr retired as executive vice president of pharmaceutical operations at Eli Lilly & Company after 32 years of service. He had been responsible for global pharmaceutical operations and sales and marketing worldwide at Lilly - a leading innovation-driven corporation. Gerhard Mayr is past chairman of both the International Executive Committee and the Europe Committee of the Pharmaceutical Research Manufacturers of America. He was a board member of the European Federation of the Pharmaceutical Industry from 1995-97 and 2000-2002. Member of the Board of Bank Austria-Creditanstalt AG, and a member of the board of OMV AG. He is a member of the Apax Healthcare Advisory Board, a member of the board of Project Hope, and a board member of the Vienna Science-Research and Technology Foundation.
| Organization | Position | Status |
|---|---|---|
| UCB Pharma Inc. | Independent Director | Current |
| OMV AG | Member of the Board | Current |
| UCB Pharma Inc. | Board of Directors | Current |
| UCB, S.A. | Board of Directors | Current |
| Carniking.Com | Board of Directors | Current |
| Larex Inc | Board of Directors | Current |
| Lonza Biologics and Celltech Therapeutics Ltd | Board of Directors | Current |
| Carnipure | Board of Directors | Current |
| Niacinamide | Board of Directors | Current |
| Lonza Inc. | Board of Directors | Current |
| High Performance Materials | Board of Directors | Current |
| Metaldehyde | Board of Directors | Current |
| Lonzapcproducts | Board of Directors | Current |
| Biocatalytics, Inc. | Special Advisor To the Codexis Board | Current |
| Highland Ophthalmology Associates, LLC | Board of Directors | Current |
| Alcon, Inc. | Board of Directors | Current |
| Natrulon | Board of Directors | Current |
| Lonza Group Ltd. | Board of Directors | Current |
| Codexis, Inc. | Board of Directors | Current |
| Carnitine | Board of Directors | Current |
| Hcnderivatives | Board of Directors | Current |
| Highland Ophthalmology Associates, LLC | Committee Member | Current |
| Eli Lilly and Company | Executive Vice President | Former |
| Eli Lilly and Company | Sales Representative | Former |
| Pharmaceutical Research and Manufacturers of America | chairman | Former |
| Swiss Federal Institute of Technology | Masters Degree In Chemical Engineering | Former |
| Stanford University | Master of Business Administration | Former |
| Guidant Corporation | member | Former |
| OMV AG | member | Former |
| Project Hope | member | Former |
| UCB Pharma Inc. | Member | Former |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Lonza Group Ltd. | Board of Directors | Current |
Executive News
-
Japan approves first generic biotech drug
Industry Transcripts by Seeking Alpha
-
Valspar Corp. F4Q09 (Qtr End 30/10/09) Earnings Call Transcript
on Nov 23, 2009about VAL
-
Donaldson Company Inc. F1Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Nov 19, 2009about DCI
-
La-Z-Boy Inc. F2Q10 (Qtr End 10/24/09) Earnings Call Transcript
on Nov 18, 2009about LZB
-
KongZhong Q3 2009 Earnings Call Transcript
on Nov 11, 2009about KONG
-
Harbin Electric, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about HRBN
Glass Door
Manufacturing Industry Companies
| Company | Employer Rating |
| Alcoa |  |
| United Technologies | |
| BAE SYSTEMS (United Kingdom) | |
| Textron |  |
| Boeing | |
IndustryTop Rated
